• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Major China Pharmaceutical R&D Global Summit to Take Place September 18-21, 2005 in Shanghai, China

Posted on: Wednesday, 31 August 2005, 09:00 CDT

NEW YORK, Aug. 31 /PRNewswire/ -- With growth rates declining in established markets, the pharmaceutical industry has turned its attention to less established countries for new avenues of growth. While China is an obvious target because of its huge population and booming economy, other emerging markets such as India, Eastern Europe, and South America have also garnered the industry's attention. How does China compare to these other emerging markets? Important issues such as conformity to global standards, regulatory environment, future potential for in-market sales, and protection of intellectual property are the criterion from which the pharmaceutical industry is measuring their level of potential investment. Is China the pharmaceutical industry's greatest opportunity for growth?

"Impact China: Pharmaceutical R&D Global Summit 2005," a conference organized by the Strategic Research Institute will explore why many regard China as the next frontier for the pharmaceutical industry. Scheduled to take place on September 18-21, 2005 in Shanghai, China, this groundbreaking event will lend a platform for the scientific and business leaders in the pharmaceutical industry to discuss the opportunities and challenges ahead in the rapidly developing Chinese market.

Through a variety of case study presentations, panel discussions, keynote addresses, and focused workshops, the conference will comprehensively address the critical issues driving interest in China's emerging pharmaceutical market.

Over 50 Speakers Will Cover Important Conference Topics Including: * Successful Interaction with the Chinese State Food Drug & Administration (SFDA) * Intellectual Property & Patent Enforcement in China * Planning & Management of Global Clinical Trials with Enrollment in China * A Comparison of China vs. India: Similarities & Differences in Clinical Trials and R&D * Strategic Partnerships with CROs in China * Speeding Up Drug Discovery & Development through China-Based Operations * Application of Project & Risk Management in the Process of Building China's Pharmaceutical Industry * East/West Partnerships: How to Find Potential Partners * Venture Capital Investment in the Chinese Pharmaceutical Market

For the full agenda, to register for the conference, or to inquire about the sponsorship & exhibition opportunities offered, please contact the event director, Jon E. Liong at jliong@srinstitute.com or call (212) 967-0095 x243.

Conference Website: http://www.srinstitute.com/china

Strategic Research Institute

CONTACT: Jon E. Liong, Senior Vice President, Life Sciences of StrategicResearch Institute, +1-212-967-0095 ext. 243, jliong@srinstitute.com

Web site: http://www.srinstitute.com/http://www.srinstitute.com/china

Source: PRNewswire

More News in this Category